Press-release for stocks related to biopharma for ILMN

Prices are updated after-hours

Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials
Published: 2023-09-19 (Crawled : 13:00) - globenewswire.com
MYGN F | $18.515 0.03% 0.03% 490K

| 8.63% | O: -0.06% H: 2.29% C: 2.0%
ILMN | $117.43 0.63% 0.63% 1.4M

| -17.54% | O: -0.81% H: 0.28% C: -0.51%
partnership biopharma trials

| 8.86% | O: 0.24% H: 1.11% C: -1.82%
GLW M | $31.27 1.17% 0.0% 4.6M

| -18.61% | O: 0.52% H: 1.98% C: 0.91%
ILMN | $117.43 0.63% 0.63% 1.4M

| -70.71% | O: 1.75% H: 2.31% C: -2.06%
biopharma gene therapies life science growth therapy gene therapy

67%

33%

Save your searches and get alerts when important news are released.